This inventor holds 1 USPTO granted patent. Top assignee: Microbia, Inc.. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Innovations by Eduardo Martinez in the Field of Hypercholesterolemia Treatment
Introduction
Eduardo Martinez is an accomplished inventor based in New York, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of hypercholesterolemia. His innovative work has led to the development of a unique compound that holds promise for improving health outcomes.
Latest Patents
Eduardo holds a patent for "4-Biarylyl-1-phenylazetidin-2-ones." This patent discloses compounds that are useful for the treatment of hypercholesterolemia. The compounds are characterized by a general formula where specific residues and chains are defined, showcasing the complexity and potential of his invention.
Career Highlights
Eduardo is currently associated with Microbia, Inc., where he continues to push the boundaries of pharmaceutical research. His work is instrumental in developing new treatments that can significantly impact patient care and health management.
Collaborations
Eduardo collaborates with talented individuals such as Regina Lundrigan-Soucy and Jing-Jing Yang. These partnerships enhance the innovative process and contribute to the success of their projects.
Conclusion
Eduardo Martinez's contributions to the field of hypercholesterolemia treatment through his patent demonstrate his commitment to advancing medical science. His work at Microbia, Inc. and collaborations with esteemed colleagues further highlight his role as a key innovator in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile